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Background: Polygonum minus Huds.is a culinary flavouring that is common in South East Asian cuisine and as a
remedy for diverse maladies ranging from indigestion to poor eyesight. The leaves of this herb have been reported
to be high in antioxidants. Flavonoids which have been associated with memory, cognition and protection against
neurodegeneration were found in P. minus.
Method: This study examined a P. minus aqueous extract (Lineminus™) for its antioxidant activity using the Oxygen
Radical Absorbance Capacity (ORAC) assay, the ex vivo Cellular Antioxidant Protection of erythrocytes (CAP-e) assays
and for potential anticholinesterase activity in vitro. Cognitive function and learning of Lineminus™ was evaluated
using scopolamine induced cognition deficits in a Barnes maze, rodent model of cognition.
Results: The extract displayed in vitro antioxidant activity with a total ORAC value of 16,964 μmole TE/gram. Cellular
antioxidant protection from free radical damage using the CAP-e assay, with an IC50 of 0.58 g/L for inhibition of
cellular oxidative damage, was observed. The extract inhibited cholinesterase activity with an IC50 of 0.04 mg/ml
with a maximum inhibition of 68%. In a rodent model of cognition using scopolamine induced cognition deficits in
the Barnes maze, the extract attenuated scopolamine induced disruptions in learning at the higher dose of
100 mg/kg.
Conclusion: These data shows that P. minus possesses antioxidant and anticholinesterase activity and
demonstrated enhanced cognition in vivo. The data suggest neuroprotective properties of the extract.
Keywords: Scopolamine, Antioxidant, Barnes maze, Polygonum minus, CognitionBackground
Polygonum minus Huds. synonymous to Persicaria minor
is from the family Polygonaceae and is commonly referred
to as Kesum or laksa leaf in Malaysia. It is used as a fla-
vouring ingredient in culinary dishes and also consumed
as an ulam (salad) for preventive healthcare [1,2]. Tra-
ditionally, the decoction of leaves is taken for indigestion,
after childbirth, to warm the body up and to promote* Correspondence: annie.g@biotropicsmalaysia.com
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unless otherwise stated.good eyesight [3]. It is possible that P. minus has the abil-
ity to increase blood circulation [4].
Several studies have shown that leaves of P. minus are
high in antioxidants [5-9]. It has been reported that water
extracts of P. minus have shown superior antioxidant
activity when compared to other popular herbs such as
ulam raja, selom, pegaga and curry leaves, where antio-
xidant activity was similar to the synthetic antioxidant
butylhydroxytoluene (BHT) [6]. Water extracts of P.
minus had higher antioxidant activity, measured by the
total phenolic content (TPC), when comparing to ginger
(Zingiber officinale) and turmeric (Curcuma longa) [9],Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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ric reducing antioxidant power (FRAP) [7]. Polygonum
minus was shown to possess 98.3% of lipid peroxidation
inhibitory activities and is proposed as a candidate for
nutraceutical and cosmeceutical product [2]. It has also
been reported to be rich in vitamins such as carotenes, re-
tinol equivalents and vitamin C, α-tocopherol (vitamin E)
and minerals such as calcium, phosphorus, iron, sodium,
potassium, magnesium, copper and zinc [10].
Free radicals, including reactive oxygen species, have
been shown to cause aging and several degenerative dis-
eases such as atherogenesis, cardiovascular and neurode-
generative diseases [11,12]. Although the production of
free radicals is a normal by-product of metabolism and
environmental stress, the over production leads to cell
damage. For this reason, antioxidants such as vitamins
A, C, E, carotenoids and plant polyphenols (flavonoids,
phenolic acids, cathechins, coumarins, tannins and an-
thocyanins) are commonly consumed as part of the food
composition as a protective defence mechanism against
such damage. Plant antioxidants can therefore act as
agents in scavenging reactive oxygen species.
Phytochemical screening of P. minus have shown the
presence of flavanoids, flavones, cathecin, epicatechingal-
late and terpenoids [5]. Flavonoid and polyphenols have
been long studied for their strong antioxidant capacities,
and their ability to scavenge reactive oxygen species thus
preventing aging and oxidative stress related diseases
[13,14]. Studies also show that flavonoids have an effect
on memory, cognition and against neurodenegeration and
the ability to improve cerebrovascular blood flow [15].
The nutraceutical industry uses a standardized chemical
antioxidant method, ie. the Oxygen Radical Absorbance
Capacity (ORAC) test to evaluate antioxidant strength.
The ORAC is a HAT-based assays measuring the capabi-
lity of an antioxidant to quench free radicals (generally,
peroxyl radicals) by H-atom donation [16]. In addition,
the ORAC assay measures the degree and length of time
the extracts take to inhibit the action of an oxidizing agent
unlike the DPPH assay. The ORAC was identified as one
of the best standardized antioxidant assay for the natural
products industry in measuring antioxidant levels in nutri-
tional and natural products [17-19]. The U.S. Department
of Agriculture developed a database of biological materials
and foods to provide the basis for comparing antioxidant
strength based on ORAC values [20]. This enables one to
compare the antioxidant levels against other popularly
known antioxidant foods hence making it easier to
compare the antioxidant effect of P. minus as a food with
other more established high antioxidant foods. The ORAC
assay has since been commercialized by Brunswick Labs,
Wareham, MA, USA. The DPPH and FRAP method on
the other hand is a SET method, which measures the
ability of the antioxidant to transfer one electron to reducea specific oxidant. In the case of DPPH assay, it measures
direct reactions with the DPPH radical, which is de-
pendent on the structure of an antioxidant compound
therefore only giving a general indication of the radical
scavenging abilities of antioxidants.While DPPH method
is a rapid and convenient method to measure antioxidant
activity it diverges from biological conditions the most, by
the use of an artificial DPPH radical and methanol as the
solvent [21]. This is in contrast to ORAC which is per-
formed at a physiological pH producing a biologically rele-
vant radical, the peroxyl radical [22].
However, there is a need to demostrate the antioxidant
capacity in serum to show bioavailibity. Since a clinical
trial is costly and time consuming, a more intermediary
cell-based study was developed to test to what extent a
substance protects against oxidative stress in a biologi-
cally relevant sytem. The Cellular Antioxidant Protection
of erythrocytes (CAP-e) assay is a cell-based antioxidant
protection assay using erythrocytes to address the ques-
tion of whether antioxidants in complex natural pro-
ducts enter the cytosol and contribute to the reduction
of oxidative damage within the cell [23] and was suc-
cessfully applied in other antioxidant rich herb and fruit
such as the Acai berry [24]. The current study is an
attempt to draw a parallel between the antioxidant pro-
perty of the herb, its’ relevance in a biological system,
using the CAP-e assay (ex vivo) and the improvement of
learning and memory in vivo as one of the manifestation
of the antioxidant property.
As improvements in cogniton may be multi-pronged,
the herb is also tested for antiacetylcholinesterase activ-
ity. Acetylcholine is a neurotransmitter related to learn-
ing and memory [25]. It is metabolised by the enzyme
acetylcholinesterase. Inhibition of acetylcholinesterase is
presently the most accepted and recognized therapeutic
marker for the development of cognitive enhancers [26].
Anti-cholinesterase activity has never been tested for P.
minus. Screening for herbal plants with acetylcholin-
esterase inhibitory activity would open new possibilities
for cognition improving herbal products.
Several in vivo models have been used to investigate
learning and memory in animal models of which Scopo-
lamine, a muscarinic receptor antagonist, produce deficits
in spatial navigation tasks in rodents [27]. Scopolamine
significantly increases acetylcholinesterase (AChE) and
malondialdehyde (MDA) levels in the cortex and hippo-
campus [26].
The Barnes maze was developed as a sensitive tool for
testing hippocampus-dependent spatial memory in rats
[28] and is the model adopted for this study. In addition,
for mice the Barnes maze is better, as they swim less well
than rats. The Barnes maze is similar to the Morris
water maze task, but does not utilize a strong aversive
stimulus (stress induced by swimming as reinforcement).
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fluence the animal's performance [29].
This study was performed to investigate P. minus in
protecting against oxidative stress in a cell-based study
and in memory improvement in vivo. Currently the plant
extract most popularly researched for the ability to en-
hance cognition is Gingko biloba. Extracts of G. biloba
were shown to improve memory and normalizing cogni-
tive deficits in animal models [30], and in treatment of
cognitive improvement in Alzheimer’s patients [31]. In
this study, the antioxidant activity of P. minus was tested
in vitro and the protection against oxidative damage de-
monstrated in red blood cells. The paper attempts to draw
a parallel between the protective antioxidant affect of the
herbal extract to the cognition enhancing effect, in an
animal model induced with cognitive deficits by scopo-
lamine, whose activity can also be attenuated by an anti
acetylcholinesterase. The activity of the herb was com-
pared to the more traditionally and scientifically docu-
mented, G. biloba which has been reported to possess




Polygonum minus was procured from Biotropics Malaysia
Berhad, Malaysia. The plant material was identified based
by a Taxonomist from Institute Bio Science, University
Putra Malaysia (UPM) based on their exomorphic cha-
racters and literature review of the plant. The voucher
specimen of the plant (SK 2077/12) was deposited in the
Herbarium Institute Bioscience, UPM Malaysia. The aerial
parts of plants including stem and leaves were extracted
to produce an aqueous extract for in vitro and in vivo
assays.
Plant extract
Fresh plant material was oven-dried to below 10% mois-
ture content. The dried leaves were chopped into frag-
ments and the extraction was performed by immersing
these leaves in water at a ratio of 1:20 and percolated for
2 cycles for 4 hours at 80°C. The liquid was then filtered
and evaporated. The liquid concentrate was subsequently
freeze dried until it reached a moisture content of below
8% w/w. The extract was then vacuum packed in alu-
minum foil to preserve it in a cool low humidity with no
direct exposure to sunlight. The water extract of P. minus,
standardised to Quercetin-3-glucuronide 0.59% and 0.27%
Quercitrin was prepared by Biotropics Malaysia Berhad
according to process outlined in Malaysian Patent Pen-
ding No. PI2012003882 [32]. The HPLC fingerprint
(Figure 1A) of P. minus water extract was obtained ac-
cording to the HPLC method using Kinetex 1.7 μm C18
(2.1 × 150 mm) column. The mobile phase consisted ofsolvent A-0.10% formic acid in water and B-0.10% formic
acid in acetonitrile mixed according to a linear gradient
program of between 5-89% of solvent A and 95-11% of
solvent B. Two major peaks in the fingerprint profile were
isolated and identified to be quercetin-3-glucuronide and
quercitrin based on their mass(es) and MS fragmenta-
tions. LC-MS-MS was performed using a Shidmadzu
UFLC system equipped with a PDA and IT-TOFMS.
Peaks at retention times 7.15 and 13.96 min identified
as Quercetin glucuronide and Quercitrin respectively
were further confirmed by comparing their retention
time values and the obtained UV max with those of the
standards. (Figure 1A-C).
The comparative plant extract of Gingko biloba was
based on commercially available standardised extract of
dried leaf from Shanghai Novanat Co. Ltd. The extract
was standardised to 27.25% Gingkoflavoglycosides, 6%
Terpene lactones and ≤ 5 ppm Ginkgolic acid determined
through HPLC methods and passed microbial and heavy
metal test (based on the Certificate of Analysis).
Determination of antioxidant capacity using ORAC assay
Extract of P. minus was shipped to Brunswick Labora-
tories, Norton, MA, an independent contract laboratory
specialising in standardised natural product assays, to test
for ORAC values. Data were obtained for ORAC hydro-
philic testing using fluorescein as the fluorescent probe
and 2,2′-azobis (2-amidinopropane) dihydrochloride as a
peroxyl radical generator, ORAC lipophilic testing for lipid
antioxidants capable of quenching peroxyl free radicals,
HORAC testing for antioxidants capable of quenching hy-
droxyl free radicals, NORAC testing for antioxidants cap-
able of quenching peroxynitrite, and SORAC testing for
superoxide dismutase-like activity (based on Certificate of
Analysis released by the lab) [33].
Determination of CAP-e antioxidant capacity
The CAP-e antioxidant capacity was estimated according
to the modified method of Honzel [23], modified for a
more sensitive and accelerated protocol [33]. An amount
of 0.5 g of plant extract was mixed with 5 mL 0.9%
saline at physiological pH, mixed by inversion, vortexed
and allowed to incubate on a rocker for 20 minutes. The
solids were removed by centrifugation at 2400 rpm for
10 minutes. The supernatant was removed and then
filtered through a 0.22 micron cellulose acetate syringe
filter before use in the CAP-e assay. Serial dilutions were
prepared from the filtered supernatant in 0.9% saline at
physiological pH. Red blood cells were treated in dupli-
cate with serial dilutions of the test product. Samples of
untreated red blood cells (negative controls) and samples
of red blood cells treated with oxidizing agent but not
with an antioxidant-containing test product (positive
controls) were prepared in hexaplicate. The antioxidants
Figure 1 HPLC profile of Polygonum minus water extract. A. The peaks correspond to 2 compounds identified as Quercetin-3-glucuronide
and Quercitrin identified at RT 7.150 min and 13.975 min, respectively. B. The UV spectrum of Quercetin-3-glucuronide identified with respect to
its’ retention time. C. The UV spectrum of Quercitrin identified with respect to its’ retention time.
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tion and aspiration of supernatant above the cell pellet.
The cells were exposed to oxidative damage by ad-
dition of the peroxyl free-radical generator 2,2’ azobis
(2-amidinopropane hydrochloride) (AAPH). Using the
indicator dye Dichlorofluorescein diacetate (DCF-DA),
which becomes fluorescent as a result of oxidative dam-
age, the degree of antioxidant damage was recorded by
measuring the fluorescence intensity of each sample in a
TECAN Spectrafluor plate reader. The inhibition of oxi-
dative damage was calculated as the reduced fluores-
cence intensity of product-treated cells, compared to
cells treated only with the oxidizing agent, in reference
to the baseline levels of oxidation in untreated cells. The
CAP-e value which is in Gallic Acid Equivalent (GAE)
units, reflects the IC50 dose of the test products, i.e. the
dose that provided 50% inhibition of oxidative damage.
This is then compared to the IC50 dose of the known
antioxidant Gallic acid.
Determination of anticholinesterase activity
The extracts was screened for anticholinesterase activity
using ProfilingScreen procured from Ricerca Pharmaco-
logy Services, Taiwan. The extract was tested in duplicates
at a concentration of 10, 30 and 100 μg/ml. Concurrent
vehicle 1% DMSO and reference standard Physostigmine
were conducted with each assay using Human Recom-
binant HEK-293 cells.
Animals
Two to six month old adult male C57BL/6 mice (20–
25 g), (n = 12–14) were supplied by BioLASCO (Taiwan).
The mice were group-housed under a 12/12-h light/dark
(200–300 Lux) cycle (lights on 07:00 h) with free access to
food (Labdiet, formulated laboratory chow) and water andhumidity kept between 50%–70%. The experiment was
approved by the Institutional Animal Care and Use
Committee of Cerca Insights Sdn Bhd and was conducted
in accordance with the Singapore NACLAR Guide (2004)
for the care and use of laboratory animals.
Treament
Herbal extract treatments of 50 mg/kg P. minus, 100 mg/kg
P.minus, 50 mg/kgG.biloba or vehicle (water) were given
daily via oral gavage for fourteen days prior to Barnes
maze testing. This treatment continued during the five
days of Barnes maze testing. During the Barnes maze tes-
ting these mice received i.p. injections of either scopola-
mine (0.5 mg/kg) or saline vehicle. A further group
received i.p. injections of donepezil (1 mg/kg) and scopo-
lamine (0.5 mg/kg). The dose and time of scopolamine
administration has been previously shown to produce
deficits in spatial navigation tasks in rodents [27].
Barnes assay
The Barnes maze (BM) was created to evaluate spatial
learning [18,26]. The Barnes maze consisted of a PVC
circular platform with 21 holes placed 6 cm from the
edge and equally distributed around the surface. The
platform was 122 cm in diameter and 92 cm from the
ground. The maze uses rodents natural aversion to open
illuminated places and so the subjects were motivated by
bright light (Lux level 300 – 500) to locate an escape
hole which leads to a dark box (5.4 × 23 × 4.5 cm).
Room design and equipment around the maze were used
as fixed spatial cues (extra-maze cues) for navigational
purposes.
Barnes maze testing consisted of three phases, an
adaptation period, an acquisition period and a probe
trial. A pre-trial (adaptation period) was given prior the
Table 1 Total ORACFN showing a measure of the total
antioxidant power of P.minus aqueous extract against
the five predominant reactive species
Antioxidant power against peroxyl radicals 2,591 μmole TE/gram
Antioxidant power against hydroxyl radicals 8,973 μmole TE/gram
Antioxidant power against peroxynitrite 222 μmole TE/gram
Antioxidant power against super oxide anion 4,039 μmole TE/gram
Antioxidant power against singlet oxygen 1,139 μmole TE/gram
Total ORACFN (sum of above)* 16,964 μmole TE/gram
*Brunswick Laboratories, USA [34].
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went four trials per day for four days (acquisition period)
and then a probe trial was performed twenty-four hours
after the final acquisition trial. Thirty minutes prior to
the first trial the test subjects received an injection of
either scopolamine, saline vehicle, or scopolamine and
donepezil.
Adaptation period
The subject was placed in the center zone of the maze,
shrouded in a chamber for 10 seconds. The chamber
was removed and the subject was allowed to explore the
maze for 30 seconds, then gently guided to the escape
hole. If the subject did not then enter the escape hole, it
was placed inside. The hole was then covered and the
subject remained there for 3 minutes. The subject was
then returned to its home cage and the platform cleaned
with 70% ethanol.
Acquisition period
The chamber was removed and the subject was allowed to
explore the maze for 5 minutes and then gently guided to
the escape hole. If the subject did not then enter the
escape hole, it was placed inside. The hole was then co-
vered and the subject remained there for 1 minute. The
subject was then returned to its home cage and the plat-
form cleaned with 70% ethanol. The next trial was run
after following an inter-trial interval of two minutes.
Probe trial
For the probe trial, an identical white disc was placed on
the platform that covered all the holes. The subject was
placed in the center zone of the maze, shrouded in a
chamber for 10 sec. The chamber was removed and the
subject was allowed to explore the area for 90 seconds.
The subject was then returned to its home cage and the
platform cleaned with 70% ethanol.
The behavior of the experimental subjects was captured
by video camera and recorded on the hard drive of a desk-
top PC. An analysis of these recordings was performed
using EthoVision® XT tracking system for the automatic
tracking and analysis of animal movement. For each par-
ameter, the performance in the trials on each day were
averaged. The following parameters were measured during
the test and processed - (i) Total path length, the distance
moved by the subject during the entire session. Total path
length is the total distance moved over the whole time of
the experimental trial including the distance moved after
the first encounter with the escape-hole (when the mouse
has encountered the escape hole but failed to enter it). An
increase in path length demonstrates a decrease in per-
formance; (ii) Total errors, the count of the number of
errors made by the subject throughout the trial. Total
errors are the number of approaches to the non-escapehole, when the mouse has interacted with the escape hole
but not escaped and further explored the maze. Both total
path length and total errors measure learning; (iii) Total
latency, the latency for subject to complete the task. Total
latency describes the time taken by the mouse to enter the
escape hole; (iv) For the probe trial the arena was divided
into 8 right equal segments and duration in each segment
by the subject was measured. The mice are allowed to ex-
plore the maze and the time the mice stay in various areas
on the maze is recorded. This ‘probe’ trial is used to assess
memory.
Data was analyzed using two-way repeated measures
ANOVA, with ‘day’ as repeated-measure factor within
subjects and ‘treatment group’ as between-subject’s factor.
Post-hoc pairwise comparisons between groups using
Tukey HSD test were carried out if significant effect was
found. Data analysis was performed using Sigma Plot sta-
tistical software.
Results
Antioxidant capacity as measured by the ORAC assay and
anti-cholinesterase activity
There are five predominant reactive species found in the
body: peroxyl radicals, hydroxyl radicals, peroxynitrite,
super oxide anion and singlet oxygen. Total ORACFN
provides a measure of the total antioxidant power of a
food/nutrition product against the five predominant re-
active species. The ORACFN values for the extract are
shown in Table 1.
The extract inhibited cholinesterase activity with an
IC50 of 0.0405 mg/ml with maximum inhibition of 68%.
CAP-e assay
The CAP-e assay was used to test whether the extract
contained antioxidants capable of protecting cells from
oxidative damage. The inhibition of oxidative damage
was calculated as the reduced fluorescence intensity of
product-treated cells, compared to cells treated only
with the oxidizing agent in the absence of antioxidant
protection. The CAP-e value reflects the IC50 dose of
the extract, i.e. the dose that provided 50% inhibition of
oxidative damage. The CAP-e value for the P. minus
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per gram extract, based on an IC50 value of 0.58 g/L
(Figure 2A-B).
Learning phase (acquisition training)
A two way repeated measures ANOVA of total path
length indicated a significant effect of both treatment
(F5,72 = 4.4, p < 0.01) and day (F3,70 = 65.99,p < 0.001) as
shown in Table 2. The days one, two, three or four on
which the animal was tested is a significant factor in
performance. Post-hoc analysis showed a significant
increase in path length in the scopolamine treated con-
trol mice on days one, two and three (p < 0.05) com-
pared to vehicle treated mice indicating a scopolamine
induced deficit in learning. Hence, an increase in path
length demonstrates a decrease in performance. This
increase in path length was not seen in the mice treated
with G. biloba, donepezil or 100 mg/kg P. minus. The
scopolamine induced deficit was not reversed by treat-
ment with 50 mg/kg P. minus. These mice showed a
significant decrease in performance when compared to
vehicle treated mice on day two and three. However, the
donepezil, G. biloba and the 100 mg/kg P. minus treated
mice did not show a scopolamine induced deficit. There
was a significant effect of day (F3,70 = 62.56, p < 0.0001)
and treatment (F5,72 = 6.13, p < 0.001) on total errors. A
significant increase in total errors was seen in the sco-
polamine treated mice on days one and two (p < 0.05). A
significant increase in total errors was also seen in
P. minus (50 mg/kg) treated mice on days two and three
(p < 0.05). The deficits for total errors were not observed
after treatment with P. minus at 100 mg/kg, G. biloba or
donepezil for days one, two and three (Table 2). There
was a significant effect of day (F3,70 = 111.1,p < 0.0001)
and treatment (F5,72 = 4.94, p < 0.001) on total latency. A
significant increase (p < 0.05) in total latency was see inFigure 2 A-B Cellular antioxidant protection of erythrocytes (CAP-e) b
oxidation (untreated cells, UT), or under conditions of oxidative stress (AAP
dilutions of Polygonum minus before exposure to oxidative stress (dashed b
resulted in significant cellular antioxidant protection, shown as the dose-de
(FI) of the cells). B. The dose-dependent inhibition of cellular oxidative dam
fluorescence intensity (FI) of samples and controls: (FI(max) – FI(sample)/FI(the scopolamine and P. minus (50 mg/kg) treated mice
on days one, two and three (Figure 3).
Memory phase (probe trial)
One-way ANOVA demonstrated significant duration i.e.
time spent in the target segment in the vehicle treated con-
trol (F7,103 = 6.86, p < 0.0001); the scopolamine with done-
pezil treated (F7,111 = 6.94, p < 0.0001); the G. biloba treated
(F7,100 = 4.2333, p < 0.001) and the P. minus −100 mg/kg
(F7,95 = 6.6852, p = 0.01) mice, but not the scopolamine
alone nor the scopolamine plus P. minus- 50 mg/kg treated
mice (Table 3). This suggests that scopolamine has induced
a deficit in memory which was not reversed by the low
dose of P. minus. Both G. biloba, donepezil and higher
dose of 100 mg/kg P.minus reversed scopolamine induced
memory deficits.
Discussion
The extract was shown to possess strong antioxidant
capacity, as measured by the oxygen radical absorbance
(ORAC assay). The ORAC value of P. minus water
extract can now be compared to the more popularly
known high antioxidant foods such as Granny Smith
apples, cranberry and blueberry at ORAC values of
5381, 8983 and 9019 μmol TE/100 g respectively [20]. In
addition, the antioxidants of the standardised extract are
capable of entering into and protecting cells from oxida-
tive damage, as shown by the cellular antioxidant protec-
tion (CAP-e) assay. These properties may contribute to
the effects seen in the animal model of cognitive func-
tion, since the brain has a high level of metabolism and
oxygen use and so is susceptible to oxidative attack by
free radicals. Additionally, it has a relatively low con-
centration of anti-oxidative enzymes and free radical
scavengers [35]. Previous reports have suggested that a
water extract of P. minus promotes high antioxidanty P. minus. A. Erythrocytes were either tested for baseline levels of
H, black bar). In parallel, erythrocyte cells were exposed to serial
ars). The pre-treatment of cells before exposed to oxidative stress
pendent reduction in oxidation (measured by fluorescence intensity
age as a result of Polygonum minustreatment is shown, calculated from
max)-FI(UT)).
Table 2 Total path length travelled in the Barnes maze and total errors
Total path length (Mean ± SE) Total errors (Mean ± SE)
Treatment Day-1 Day-2 Day-3 Day-4 Day-1 Day-2 Day-3 Day-4
G. biloba 50 mg/kg 1538.99 497.76 324.95 212.4 32.35 11.9 9.46 8.00
±185.09 ±73.89 ±82.76 ±25.16 ±3.54 ±1.69 ±2.77 ±1.34
P. minus 50 mg/kg 1420.44 732.61 556.98± 340.38 33.77 22.03 18.77 12.18
±171.2 ±137.06a 117.97a ±65.71 ±3.67 ±4.25a ±3.83a ±2.41
P. minus 100 mg/kg 1436.37± 602.87 356.95± 244.47 31.92 15.71 10.85 7.88
160.44b ±96.82 51.28 ±26.89 ±3.06 ±2.2 ±1.78 ±1.18
Donepezil 1 mg/kg 1031.39 559.37± 396.59± 305.24 20.79 12.95 11.36 9.00
±173.06b 137.29 71.57 ±36.59 ±3.65 ±2.5 ±1.6 ±1.09
Veh/Sco 1841.41± 817.31 ± 1 537.84± 365.66 44.06 21.65 16.58 13.00
238.12a 90.27a 111.44a ±86.44 ±5.22a ±3.91a ±3.27 ±2.74
Veh/Veh 926.06 ± 1 234.06 ± 2 202.36± 211.82 19.09 6.75 5.98 6.40
96.13b 7.8b 24.26 ±30.61 ±3.19 ±1.24 ±0.87 ±1.27
aSignificance when compared to control vehicle + vehicle, p < 0.05.
bSignificance when compared to control vehicle + scopolamine, p < 0.05.
Veh = vehicle; Sco-Scopolamine; Don = Donepezil.
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DPPH radical and the ability of antioxidant in this plants
extract to reduce ferric (III) iron to ferrous (II) iron in
FRAP reagent, probably as a result of high flavonoid and
total phenolic content [6,9]. Using different methods to
measure antioxidant property, the antioxidant property
for water extracts of P. minus was demonstrated and by
evaluating ORAC values, the standardised P. minus
extract-Lineminus™ could be compared with other anti-
oxidant foods.
In this study, we managed to evaluate antioxidant
effect ex-vivo by the use of erythrocyte cells (in the
CAP-e bioassay study), where oxidative stress was re-
duced in a dose dependent manner by the presence ofFigure 3 Total latency in the time taken to escape. Scopolamine
treated mice showed a significant increase in latency when compared
to vehicle treated mice (*P > 0.05). Total latency decreases for all
treatments over time.the extract. Natural products including flavonoids that
exhibit anti-oxidative effects have been found to attenuate
memory impairments [24]. Some isolated antioxidant
compounds, including luteolin, quercetin, and dihydro-
kaempferol, from Acai fruit pulp had the capacity to enter
live cells and protect them from oxidative damage,
demonstrated by using the same Cellular Antioxidant Pro-
tection in erythrocytes (CAP-e) bioassay [24]. Some flavo-
noids in fact have been reported to cross blood brain
barrier in vitro [36]. The in vivo studies showed that flavo-
noids are able to be absorbed after oral administration,
pass the blood–brain barrier and do have various effects
on the CNS [37]. Derivatives of quercetin and flavonoids
were identified in extracts of P. minus [8], possibly leading
to the CAP-e effect observed in this study. However, the
concentrations of flavonoids and their metabolites which
reach the brain in the current study have to be assessed. If
this antioxidant activity is confirmed in vivo, this could
help reduce increased oxidative stress such as that re-
ported to occur in the aging brain and so may be the-
rapeutically useful. Hence the possibility of flavonoids of
P. minus to cross blood brain barrier thus qualifying the
procognitive effect in the animal study conducted here,
should be further investigated.
In the present study, scopolamine treatment induced
deficits during the early part of the acquisition (learning)
phase of the Barnes maze task. The scopolamine induced
deficits in learning were evidenced by an increase in the
number of errors, latency, and path length. Considering
the learning curve, the impairment of scopolamine treated
animals seemed most pronounced early in training, after
which some constancy was reached between the treatment
groups. This is best illustrated by the increased path
Table 3 Duration in target segment during probe trial
Duration in target segment during probe trial (sec)
Day Treatment Mean SE F value P value
5 G.biloba 50 mg/kg 20.5938462 3.44090282 (7,100) = 4.2333 p = 0.0004***
5 P.minus 50 mg/kg 18.3257143 3.70012143 (7,105) = 1.7621 p = 0.1036 n.s
5 P.minus 100 mg/kg 19.7230769 2.53861445 (7,95) = 6.6852 p = 0.0015**
5 Donepezil 1 mg/kg 16.6314286 1.65977983 (7,111) = 6.9417 p < 0.0001***
5 Veh/Sco 16.5533333 2.48504781 (7,88) = 1.7926 p = 0.0999 n.s
5 Veh/Veh 19.7384615 1.69910151 (7,103) = 6.8633 p < 0.0001***
***, One-way ANOVA demonstrated significant duration in the target segment p < 0.0001.
**, One-way ANOVA demonstrated significant duration in the target segment p < 0.001.
n.s, non significant.
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and three, but not day four. These deficits were attenuated
by the positive controls – donepezil and the G. biloba ex-
tract.They have both been reported to reverse scopola-
mine induced deficits in learning [29]. The P. minus
extract, when administered at 100 mg/kg, attenuated sco-
polamine induced deficits in the acquisition phase of the
Barnes maze task.
The dose of 100 mg/kg P. minus extract also reversed
scopolamine induced deficits in the retention (probe
trial) aspect of the task. In the probe trial, all the treat-
ments except the lower dose of 50 mg/kg of P. minus
attenuated scopolamine induced deficits. These deficits
were described by no significant preference for the target
segment by the mice. The lack of effect of the lower dose
and the significant effect of the higher dose would sug-
gest that there was a dose dependent action of the
extract. The results suggest that an extract of P. minus
can attenuate scopolamine induced learning and me-
mory deficits in mice.
Decreases in cholinergic tone are associated with cogni-
tive dysfunction and are reported in neurodegenerative
diseases such as Alzheimer’s [38,39]. Increasing choliner-
gic tone ie the levels of acetylcholine with the use of cho-
linesterase inhibitors such as donepezil has been used to
address cognitive decline in mild to moderate Alzheimer’s
disease. The Barnes maze has been used to assess learning
and memory in rodents [35]. It has several advantages
over the more commonly used water maze in that it is less
stressful for mice. It is an extensively used tool in be-
havioural neuroscience to investigate spatial learning
and memory. Scopolamine which causes impairments in
Barnes maze testing can be reversed by increasing choli-
nergic tone by the administration of a cholinesterase in-
hibitor such as donepezil [35]. Memory can be divided to
short-term or long term memory where short term me-
mory refers to holding information in conscious aware-
ness for a duration of seconds whereas long term memory
holds a larger amount of information for a longer period
of time [40]. Working memory is a subset of short-termmemory, required to perform certain mental operations
during retention [41]. The Barnes radial maze has been
used to assess learning and memory including working
memory [42] seen in the animals of this study when locat-
ing the correct escape hole. Working memory errors are
scored in this task as revisits to “incorrect” holes which
subjects have already investigated within a probe trial.
Cholinergic (acetylcholine) systems influence long term
and working memory [43] as seen in the higher dose of
P. minus and G. biloba group where the animals spent a
longer duration in the target segment during probe trial as
an indicator that the target segment location is remem-
bered. The mice in lower doses of P. minus, the donepezil
and scopolamine group demonstrated a shorter period
within the target segment suggesting poorer memory for
the target segment location that it was exposed to initially
during the probe trial. The in vitro data from the present
study, demonstrates that the extract has measurable anti-
cholinesterase activity (68%), hence it may be that the
extract induced increases in cholinergic tone, additionally
providing an explanation for the attenuation of scopola-
mine induced deficits.
Scopolamine memory impairments have also been asso-
ciated with brain oxidative stress [44] and scopolamine
has been shown to trigger the induction of reactive oxygen
species and to cause free radical injuries [45]. Herbal ex-
tracts with high antioxidant activity have been reported to
scavenge free radicals and prevent scopolamine induced
lipid peroxidation [26]. P. minus has been reported to pos-
sess up to 98.3% of lipid peroxidation inhibitory activities
[2]. The antioxidant property of P. minus [8] may have
contributed to the reactive oxygen species scavenging ac-
tivity thus improving cognition and protecting against
cognition decline [15]. It has been suggested that some of
these antiamnesic effects are a direct result from antioxi-
dant activity.
In considering human dosage, safety has been demon-
strated in the acute toxicity test where oral administration
of 2000 mg/kg of the standardised P. minus extract used
in this study produced neither mortality nor changes in
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paper reported in subacute 28-days for the dose of
1000 mg/kg, the no-observed-adverse-effect-level (NOAEL)
of the extract was found to be more than 1000 mg/kg
body weight in Wistar rats. Blood chemistry analysis
including total protein, albumin, globulin, alanine trans-
aminase (ALT), aspartate transaminase (AST), alkaline
phosphatase (ALP), glucose, creatinine, urea nitrogen,
total billirrubin, calcium, phosphorous, cholesterol, tri-
glycerides, sodium and potassium and haemotological
analysia in animals of both sexes, showed no significant
changes at 1000 mg/kg.
In a recent randomized, double-blind, placebo-con-
trolled crossover study of a propriety herbal blend (Super-
Ulam) containing 150 mg of P. minus water extract as one
of its ingredient, natural ingredients in brain health of
individuals aged 35–65 years of age was evaluated [47].
There was an improvement in cognitive function based on
computer assisted testing, demonstrated by a significant
improvement from baseline in executive functioning,
cognitive flexibility, reaction time, and working memory
in subjects on the propriety herbal blend. There was a sig-
nificant decrease in tension, depression, and anger mea-
sured by the Profile of Mood Scores (POMS) in subjects
that consumed the blend when compared to placebo. It is
possible that the improvement in cognition was a result of
P. minus which was one of its major ingredient.
Conclusion
The present study confirms that water extract of P. minus
has antioxidant activity with a high ORAC value of 16,964
μmole TE/gram and was able to reduce oxidative stress
in a dose dependent manner. Higher dose of P minus
(100 mg/kg) was able to attenuate scopolamine induced
deficit in cognition in vivo by a reduction of total path
length travelled and total errors prior to finding escape
hole and increased duration in target segment during
probe trial, indicating improved memory. These properties
suggest that further investigations into the therapeutic
potential of this extract for cognition could be a fruitful
endeavour.
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